Expertise in
3
conditions

Vincent M. Esnault

Nice, FR 
Expertise in
3
conditions
Nice, FR 
OverviewLocationsClinical Research

Overview

Vincent Esnault practices in Nice, France. Mr. Esnault is highly rated in 3 conditions, according to our data. His top areas of expertise are Membranous Nephropathy, Glomerulonephritis, Nephrotic Syndrome, Acute Tubular Necrosis, and Kidney Transplant.

His clinical research consists of co-authoring 70 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Nice, France
Other Locations
Creteil, France
Sophia Antipolis, France
Valbonne, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

Personalized Medicine for Membranous Nephropathy
Personalized Medicine for Membranous Nephropathy
Enrollment Status: Completed
Publish Date: July 25, 2025
Intervention Type: Drug
Study Drug: Rituximab
Study Phase: Phase 2
RAS Blockade at Bedtime Versus on Awakening for the Prevention of Aldosterone Breakthrough
RAS Blockade at Bedtime Versus on Awakening for the Prevention of Aldosterone Breakthrough
Enrollment Status: Completed
Publish Date: April 11, 2024
Intervention Type: Other
Study Phase: Not Applicable
Arterial Calcifications: Role of Tissue-nonspecific Alkaline Phosphatase in Phosphate and Pyrophosphate Homeostasis. PIPAL Study.
Arterial Calcifications: Role of Tissue-nonspecific Alkaline Phosphatase in Phosphate and Pyrophosphate Homeostasis. PIPAL Study.
Enrollment Status: Completed
Publish Date: April 11, 2024
Intervention Type: Other
Study Phase: Not Applicable
A 28-week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center, Study in Recombinant Human Erythropoietin (rhEPO) naïve Non-dialysis Participants With Anemia Associated With Chronic Kidney Disease to Evaluate the Efficacy, Safety and Effects on Quality of Life of Daprodustat Compared to Placebo
A 28-week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center, Study in Recombinant Human Erythropoietin (rhEPO) naïve Non-dialysis Participants With Anemia Associated With Chronic Kidney Disease to Evaluate the Efficacy, Safety and Effects on Quality of Life of Daprodustat Compared to Placebo
Enrollment Status: Completed
Publish Date: April 02, 2024
Intervention Type: Drug
Study Phase: Phase 3
Phospholipase A2 Receptor (PLA2R1) Autoantibodies in Membranous Nephropathy in Kidney Transplantation
Phospholipase A2 Receptor (PLA2R1) Autoantibodies in Membranous Nephropathy in Kidney Transplantation
Enrollment Status: Completed
Publish Date: February 12, 2024
Intervention Type: Other
Study Phase: Not Applicable
Bariatric Surgery for Obese Patients With Chronic Renal Insufficiency
Bariatric Surgery for Obese Patients With Chronic Renal Insufficiency
Enrollment Status: Terminated
Publish Date: February 05, 2024
Intervention Type: Procedure
Study Phase: Not Applicable
Non-Interventional, Exploratory, Phase IV, Single-Blind, Cross-Sectional, Randomised, Cross-over Study Evaluating Patient Palatability and Preference of 3 Potassium Binders in Patients With Chronic Kidney Disease & Hyperkalaemia (APPETIZE).
Non-Interventional, Exploratory, Phase IV, Single-Blind, Cross-Sectional, Randomised, Cross-over Study Evaluating Patient Palatability and Preference of 3 Potassium Binders in Patients With Chronic Kidney Disease & Hyperkalaemia (APPETIZE).
Enrollment Status: Completed
Publish Date: November 07, 2023
Intervention Type: Drug
ALdosterone Antagonist Chronic HEModialysis Interventional Survival Trial (ALCHEMIST), Phase III b
ALdosterone Antagonist Chronic HEModialysis Interventional Survival Trial (ALCHEMIST), Phase III b
Enrollment Status: Completed
Publish Date: October 10, 2023
Intervention Type: Drug
Study Drug: Spironolactone
Study Phase: Phase 3
Randomized Controlled Study Evaluating the Effect of a Biotherapy Treatment (Anti-RANKL Ligand Antibody: Denosumab) on Bone and Vascular Metabolism in Osteoporotic Chronic Kidney Disease
Randomized Controlled Study Evaluating the Effect of a Biotherapy Treatment (Anti-RANKL Ligand Antibody: Denosumab) on Bone and Vascular Metabolism in Osteoporotic Chronic Kidney Disease
Enrollment Status: Terminated
Publish Date: August 09, 2023
Intervention Type: Drug
Study Drug: Denosumab
Study Phase: Phase 4
Multicentric, Prospective Open-label Study Assessing an Algorithm-based Strategy of Eculizumab Discontinuation in Children and Adults With Atypical Hemolytic Uremic Syndrome (aHUS)
Multicentric, Prospective Open-label Study Assessing an Algorithm-based Strategy of Eculizumab Discontinuation in Children and Adults With Atypical Hemolytic Uremic Syndrome (aHUS)
Enrollment Status: Completed
Publish Date: December 06, 2019
Intervention Type: Drug
Study Phase: Phase 4
View 9 Less Clinical Trials

70 Total Publications

Treatment of nephrotic syndrome with anti-CD20 therapies in pregnancy: a case series and review of the literature.
Treatment of nephrotic syndrome with anti-CD20 therapies in pregnancy: a case series and review of the literature.
Journal: Renal failure
Published: March 27, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Esnault's expertise for a condition
ConditionClose
    View All 14 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile